BioSpace News Archive

Pharm Country

Regeneron Provides Update on Commercial and Pipeline Progress at J.P. Morgan Healthcare Conference

Regeneron Pharmaceuticals, Inc. will provide a strategic business update to the investor community at the 37th Annual J.P. Morgan Healthcare Conference

January 7, 2019
·
14 min read
Business

Actress Vanessa Hudgens Named American Cancer Society Global Ambassador; Joins Super Bowl Sweepstakes

The American Cancer Society (ACS) welcomes a new global ambassador, actress Vanessa Hudgens, who is participating in an exclusive Super Bowl LIII weekend package to raise critical funds to fight cancer.

January 7, 2019
·
5 min read
Business

Cardiovascular Systems, Inc. Announces Preliminary Fiscal 2019 Second-Quarter Revenues of $60.2 Million

Company Narrows Fiscal 2019 Revenue Guidance to a Range of $243 million to $247 million

January 7, 2019
·
6 min read
Business

CANbridge Pharmaceuticals and GC Pharma Announce Greater China Licensing Agreement for Hunterase™ for Hunter Syndrome

CANbridge Pharmaceuticals Inc. announced an exclusive licensing agreement in the greater China area to commercialize Hunterase™, a human recombinant iduronate-2-sulfatase (IDS) enzyme replacement therapy for the treatment of Hunter syndrome.

January 7, 2019
·
3 min read
Deals

Vatica Health Acquires CareSync’s Technology to Expand Value-Based Care Capabilities

Vatica Health today announced it has closed on its acquisition of CareSync’s technology.

January 7, 2019
·
2 min read
BioCapital

The Vision Council Shines Light On Protecting Sight - And Health - In A Multi-Screen Era

With an increase in digital technology – most vibrantly seen at the annual Consumer Electronics Show (CES), which begins tomorrow in Las Vegas – more than half of American adults suffer adverse effects from overexposure to screens.

January 7, 2019
·
5 min read
Alligator Bioscience Launches RUBY™, a Novel Concept in Bispecific Antibody Formats

Alligator Bioscience (Nasdaq Stockholm: ATORX), announces the launch of a novel concept in bispecific antibody formats, RUBY™.

January 7, 2019
·
3 min read
TSO3 Achieves Commercial Milestone and Provides Operational Update

TSO3 Inc. announced that during its fourth fiscal quarter ending December 31, 2018, the Company received an order for the 100th unit of its industry-leading STERIZONE® VP4 Sterilizer

January 7, 2019
·
6 min read
Drug Development

DURECT Corporation Provides Corporate Update

DURECT Corporation to prioritize indications with unmet medical needs where we expect to be able to generate near-term data with the potential to create significant commercial and partnering value.

January 7, 2019
·
7 min read
Bio NC

Humacyte to Present at the 37th Annual J.P. Morgan Healthcare Conference

Humacyte announced that Jeffrey Lawson, M.D., Ph.D., President and Chief Executive Officer, will present a company overview at the 37th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, California, on Tuesday, January 8, 2019 at 9:00 a.m. Pacific Time

January 7, 2019
·
1 min read